Modernizing Data Infrastructure in

Clinical Trials: Challenges,

Opportunities, and Strategies
Introduction
Clinical trials are the foundation of medical progress, providing crucial evidence for the safety
and efficacy of new treatments and interventions. However, the traditional data infrastructure
supporting these trials often struggles to manage the increasing volume and complexity of data
generated from diverse sources. Modernizing this infrastructure is essential for improving
efficiency, reducing costs, and accelerating the development of new therapies. This report
provides a comprehensive overview of the challenges, opportunities, and key strategies for
modernizing data infrastructure in clinical research.

Challenges in Current Data Collection Methods

Traditional data collection methods in clinical trials often rely on manual processes, paper-based
records, and fragmented data sources. These approaches can lead to several challenges:
●​ Data Quality Issues: Manual data entry is prone to errors, including typographical
mistakes, incorrect data entry, and missed entries, which can compromise the quality of the
data and lead to inaccurate conclusions1. Inconsistent data collection methods, arising from
variations in procedures or instruments used across different sites or by different
individuals, can lead to variability in the data, making it difficult to compare and analyze
results1. Moreover, failing to validate and clean the data can result in the inclusion of
erroneous or inconsistent data in the analysis, leading to flawed conclusions1.
●​ Inefficient Data Management: Managing data from various sources, such as electronic
health records (EHRs), laboratory results, and patient-reported outcomes, can be
cumbersome and time-consuming1. Clinical research coordinators, often the first point of
contact for multiple clinical trials, are responsible for managing the increasing volume and
complexity of data. They face challenges such as tedious manual searches for data,
time-consuming and error-prone manual re-keying of data, and manual translation of data
into the required format2. Juggling multiple systems and protocols further adds to the
complexity of data management2.
●​ Limited Data Reusability: Traditional data formats and storage methods can sometimes
pose challenges to data reusability for future research or analysis due to issues like lack of
standardization and interoperability3.
●​ Security and Privacy Concerns: Inadequate data security measures can lead to data
breaches, loss of sensitive information, and regulatory non-compliance1.
●​ Lack of Real-time Insights: Traditional data collection methods often lack real-time data
monitoring capabilities, hindering the ability to identify and address potential issues
promptly4.
●​ Patient Recruitment and Retention: Recruiting and retaining a sufficient number of
participants within the required timelines is a persistent challenge. Many trials fail to meet
 their enrollment targets, leading to delays and increased costs5.
●​ Budget Management and Financial Planning: Inaccurate budgeting can lead to
insufficient funding, impacting trial progress and outcomes5.
●​ Slow and Poorly Designed Systems and Interfaces: Clinical systems often have user
interfaces that lack clear navigation, intuitive design, and smooth operation, hindering
efficient data management for research purposes2.

To further illustrate the limitations of current data collection methods, the following table
summarizes the common pitfalls and their potential solutions:

Pitfall Solution

Inadequate planning and protocol design Detailed planning and protocol

development

Insufficient training of personnel Comprehensive training programs

Inconsistent data collection methods Standardized procedures and instruments

Manual data entry mistakes Use of EDC systems

Lack of data validation and cleaning Automated data validation and cleaning

Inadequate data security Robust security measures and protocols

Poorly managed data integration Comprehensive data integration strategies

Ignoring or mishandling missing data Appropriate methods for handling missing

data

Non-compliance with regulatory Strict adherence to regulatory guidelines

requirements

Poor communication among stakeholders Effective communication strategies

Not leveraging available technologies Adoption of advanced technologies

Opportunities for Modernization
Modernizing data infrastructure presents significant opportunities to overcome these challenges
and improve the efficiency and effectiveness of clinical trials:
●​ Enhanced Data Quality: Implementing electronic data capture (EDC) systems and
automated data validation checks can improve data accuracy and completeness1.
●​ Improved Data Management: Integrating diverse data sources through interoperable
platforms can streamline data management and facilitate comprehensive analysis1.
●​ Increased Data Reusability: Standardizing data formats and implementing data
harmonization strategies can enable data reusability for future research and analysis8.
●​ Enhanced Security and Privacy: Cloud-based data storage solutions with robust security
measures can protect sensitive patient data and ensure compliance with regulatory
requirements1.
●​ Real-time Data Insights: Implementing real-time data monitoring systems can provide
immediate insights into trial progress, enabling proactive identification and resolution of
potential issues4.
●​ Improved Diversity and Inclusion: Incorporating data diversity is essential for enhancing
the safety and efficacy of drugs across different populations and addressing health
disparities10. Diverse datasets ensure that approved treatments are not only safer but also
more effective across various populations10.

Strategies for Modernizing Data Infrastructure

Modernizing data infrastructure requires a strategic approach that encompasses various
aspects of clinical trial data management:

1. Integrating Diverse Data Sources

Integrating data from various sources, including EHRs, wearable sensors, and patient-reported
outcomes, is crucial for obtaining a holistic view of patient health11. Strategies for achieving this
include:
●​ Standardizing Data Formats: Adopting common data standards, such as CDISC, can
facilitate data exchange and interoperability between different systems9.
●​ Implementing Data Harmonization Techniques: Utilizing data harmonization techniques
can address inconsistencies and variations in data collected from different sources9.
●​ Utilizing Data Integration Platforms: Implementing data integration platforms can
facilitate the seamless flow of data from various sources into a centralized repository12.
●​ Promoting Community Engagement: Partnering with local healthcare providers and
advocacy organizations can help build trust and educate underrepresented populations
about the importance of clinical trials, improving their participation10.
●​ Addressing Anonymization Challenges: Balancing the need to safeguard participant
privacy while preserving data diversity is crucial when anonymizing individual patient data
(IPD). Strategies like generalization and noise addition should be carefully considered to
maintain data quality and avoid potential biases13.
●​ Considering Social Determinants of Health: Collecting and analyzing social determinants
of health data can provide valuable insights into health disparities and inform the
 development of more inclusive clinical trials11.
●​ Decentralized Clinical Trials: Adopting decentralized clinical trials allows patients to
participate remotely, removing geographical barriers that often prevent minority groups from
participating10.
●​ Adaptive Clinical Trial Designs: Using an adaptive clinical trial design can allow for
pre-specified changes during the trial when data becomes available, including altering the
trial population to enhance diversity10.
●​ Patient-Centric Design: Prioritizing patient needs and preferences when designing data
collection tools can improve the quality of responses and overall data integrity14. Integrating
patient feedback into the design process can enhance engagement and accuracy14.

2. Enabling Data Reusability

Data reusability is essential for maximizing the value of clinical trial data9. Strategies for
enabling data reusability include:
●​ Data Standardization and Harmonization: As mentioned earlier, standardizing data
formats and implementing data harmonization techniques are crucial for data reusability9.
●​ Metadata Management: Implementing robust metadata management practices can
provide context and facilitate the understanding and interpretation of data for future use9.
●​ Data Sharing Platforms: Establishing data sharing platforms can promote collaboration
and enable researchers to access and reuse data from previous trials9.
●​ Governance Framework: A strong governance framework is essential for data reusability,
detailing the scope of acceptable secondary research activities, enforcing best practice
processes, and designating experts to evaluate research activities15.
●​ Data Compatibility Assessment: Defining a list of compatible uses of clinical data based
on their contextual integrity and conducting comprehensive assessments of legacy data or
new reuse purposes are crucial for ensuring appropriate data reuse15.
●​ Fair Balance of Interests: Conducting risk assessments that consider potential risks to
research participants and implementing mitigating actions are necessary to ensure a fair
balance of interests when reusing clinical data15.
●​ Sound Scientific Approach: Applying the basic elements of sound scientific research
when conducting secondary research ensures the integrity of the data and its scientific
validity15.
●​ Privacy and Confidentiality Protection: Ensuring data use is consistent with participant
expectations and implementing measures to protect their privacy are crucial ethical
considerations in data reuse15.
●​ Oversight and Accountability: Continuous monitoring of data processing activities,
documentation of relevant decisions, and ensuring data traceability are essential for
demonstrating oversight and accountability in clinical data reuse15.

3. Utilizing Digital Endpoints

Digital endpoints, derived from data collected through digital health technologies (DHTs) such as
wearable sensors and mobile apps, offer opportunities to capture real-world patient data and
improve trial efficiency16. This represents a significant shift from traditional clinic-based
outcomes to remote, real-time data collection, potentially transforming how clinical trials
measure efficacy16. Strategies for utilizing digital endpoints include:
●​ Selecting Appropriate DHTs: Choosing DHTs that are fit for purpose and provide reliable
and validated data is crucial for generating meaningful insights17.
●​ Ensuring Data Quality and Validity: Implementing rigorous data quality control measures
and validating digital endpoints against traditional clinical outcomes are essential18.

Ethical Considerations for Digital Endpoints

Addressing ethical considerations is paramount when utilizing digital endpoints in clinical trials:
●​ Informed Consent and Data Privacy: Ensuring informed consent and protecting patient
privacy are crucial when collecting and using data from DHTs19.
●​ Equitable Access to Technology: In decentralized clinical trials (DCTs), it is important to
ensure that access to technology does not become an exclusion criterion and that
participants have the necessary equipment, training, and support to use the devices
effectively19.
●​ Patient Adherence and Acceptability: Considering patient needs and preferences when
designing and implementing digital technologies is crucial for promoting adherence and
acceptability of digital endpoints21.
●​ Investigator Engagement: Demonstrating the validity and value of digital endpoints to
clinical colleagues is essential to encourage their adoption and support patient adherence21.

4. Leveraging AI and Machine Learning

Artificial intelligence (AI) and machine learning (ML) can play a significant role in modernizing
data infrastructure in clinical trials22. AI has the potential to reduce the cost and time of clinical
trials while improving efficiency and drug development research23. Strategies for leveraging
AI/ML include:
●​ Automating Data Management Tasks: AI/ML can automate data cleaning, validation, and
analysis, reducing manual effort and improving efficiency23. For example, AI can intelligently
interpret data, feed downstream systems, and automatically fill out analysis reports23.
●​ Identifying Potential Trial Participants: AI/ML algorithms can analyze patient data to
identify individuals who may be eligible for specific clinical trials22. An example is TrialGPT,
an AI algorithm developed by the NIH that matches potential volunteers to relevant clinical
trials24.
●​ Predicting Trial Outcomes: AI/ML models can simulate trial outcomes and assist in
optimizing trial design and patient recruitment strategies25.
●​ Improving Patient Engagement and Retention: AI can help link participants with studies
and improve communication to enhance retention26. AI-powered chatbots can be an
effective means to educate patients and improve communication, potentially leading to
better patient engagement and retention26.

5. Fostering Collaboration and Partnerships

Collaboration among various stakeholders, including pharmaceutical companies, research
institutions, technology providers, and regulatory agencies, is essential for successful
modernization efforts27. This collaboration can be facilitated by establishing a common data
language and robust data infrastructure to support data sharing initiatives11. Strategies for
fostering collaboration include:
●​ Establishing Data Sharing Agreements: Developing clear data sharing agreements can
facilitate data exchange and collaboration among different organizations12.
●​ Participating in Industry Consortia: Joining industry consortia, such as the Clinical
Research Data Sharing Alliance (CRDSA), can promote the development and adoption of
data sharing standards9.
●​ Engaging with Regulatory Agencies: Early engagement with regulatory agencies can
ensure that modernization efforts align with regulatory guidelines and requirements10.

6. Modernizing IT Application Architecture

Modernizing the IT application architecture that supports clinical trials requires a structured
approach12. Key considerations include:
●​ Scope of Modernization: Defining the scope, whether it involves upgrading only the
application layer or embedding it into the data or infrastructure layers, is crucial12.
●​ Differentiation: Identifying areas where the organization wants to differentiate itself through
technology is important12.
●​ Application Archetype: Selecting the appropriate clinical development application
archetype that aligns with the organization's needs and goals is essential12.
●​ Vendor Selection: Choosing vendor combinations that best meet the organization's needs
and long-term platform strategy is crucial12.
●​ Joint Ownership: Ensuring joint ownership between the business and IT teams is critical
for successful implementation12.

Best practices for modernizing IT application architecture include:

●​ Transforming Processes, People, and Technology: End-to-end process optimization,
clear roles and responsibilities, and user training are essential for successful technology
implementation12.
●​ Embracing Complexity and Setting Priorities: Recognizing the complexity of the
application landscape and setting clear, value-driven priorities aligned with the pipeline are
crucial12.
●​ Prioritizing Interoperability: Seamless integration with internal and external data
infrastructures is essential for successful trial design and execution12.
●​ Defining Value and Tracking Success: Establishing financial and non-financial metrics to
track the success of modernization efforts is important12.
●​ Choosing Vendors with Long-Term Goals: Basing vendor selection on long-term platform
strategy and avoiding point solutions can ensure sustainable support12.

Conclusion
Modernizing data infrastructure in clinical trials is crucial for addressing the challenges of
managing increasing data volume and complexity, improving efficiency, and accelerating the
development of new therapies6. By integrating diverse data sources, enabling data reusability,
utilizing digital endpoints, leveraging AI/ML, fostering collaboration, and modernizing IT
application architecture, the clinical research community can unlock the full potential of data to
improve patient health and advance medical knowledge. The strategic adoption of these
approaches can lead to more efficient, cost-effective, and inclusive clinical trials, ultimately
accelerating the development of new treatments and improving patient outcomes.

Works cited

1. Pitfalls to Avoid in Clinical Data Collection and Management | IDDI, accessed February 20,
2025, https://iddi.com/resources/pitfalls-to-avoid-in-clinical-data-collection-and-management/
2. Navigating the Top 6 Data Challenges in Clinical Research, accessed February 20, 2025,
https://ignitedata.com/6-common-data-challenges-for-clinical-researchers/
3. Challenges of using real world data in research and clinical trials - Lifebit, accessed February
20, 2025,
https://www.lifebit.ai/blog/challenges-of-using-real-world-data-in-research-and-clinical-trials
4. What Is Data Collection For Clinical Trials? What Are The 11 Best Practices For Data
Collection In Clinical Trials & Its Challenges, accessed February 20, 2025,
https://llri.in/data-collection-for-clinical-trials/
5. Top 5 Challenges in Clinical Trial Study Start-up and Pipeline Management - RealTime,
accessed February 20, 2025,
https://realtime-eclinical.com/2024/06/20/top-5-challenges-in-clinical-trial-study-start-up-and-pip
eline-management/
6. 4 Ways to Improve Clinical Data Quality & Control in Modern Trials - Taliun, accessed
February 20, 2025,
https://www.taliun.com/4-ways-to-improve-clinical-data-quality-control-in-modern-trials
7. Inclusion and Diversity in Clinical Trials: Actionable Steps to Drive Lasting Change - PMC,
accessed February 20, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9133187/
8. What is Data Reusability in Healthcare? - Syntrix Consulting Group, accessed February 20,
2025, https://www.syntrixconsulting.com/blog/what-is-data-reusability-in-healthcare
9. CRDSA Announces New Standards for Clinical Trial Data Reuse | clinicallab, accessed
February 20, 2025,
https://www.clinicallab.com/crdsa-announces-new-standards-for-clinical-trial-data-reuse-28033
10. The Importance of Data Diversity to Enhance Clinical Trials Success - SOPHiA GENETICS,
accessed February 20, 2025,
https://www.sophiagenetics.com/resource/the-importance-of-data-diversity-to-enhance-clinical-tr
ials-success/
11. Five Strategies To Boost Clinical Trial Diversity - MedCity News, accessed February 20,
2025, https://medcitynews.com/2024/02/five-strategies-to-boost-clinical-trial-diversity/
12. Faster, smarter trials: Modernizing biopharma's R&D IT applications - McKinsey & Company,
accessed February 20, 2025,
https://www.mckinsey.com/industries/life-sciences/our-insights/faster-smarter-trials-modernizing-
biopharmas-r-and-d-it-applications
13. Diversity in Clinical Trial Data Transparency: A New Horizon for Data Sharing with Truthful
Statistics, accessed February 20, 2025,
https://www.appliedclinicaltrialsonline.com/view/diversity-in-clinical-trial-data-transparency-a-ne
w-horizon-for-data-sharing-with-truthful-statistics
14. 4 Way to Improve Clinical Data Quality & Control in Modern Trials - Quanticate, accessed
February 20, 2025, https://www.quanticate.com/blog/clinical-data-quality
15. 6 Key Principles to Guide the Compatible Reuse of Clinical Data, accessed February 20,
2025, https://myscrs.org/resources/reuse-clinical-data/
16. Breaking the mold: How digital endpoints could transform clinical trials, accessed February
20, 2025, https://www.clinicaltrialsarena.com/features/features-digital-endpoints/
17. Digital Endpoints: Definition, Benefits, and Current Barriers in Accelerating Development
and Adoption - PMC, accessed February 20, 2025,
https://pmc.ncbi.nlm.nih.gov/articles/PMC8490914/
18. Methods for the Clinical Validation of Digital Endpoints: Protocol for a Scoping Review
Abstract - PubMed Central, accessed February 20, 2025,
https://pmc.ncbi.nlm.nih.gov/articles/PMC10636620/
19. Decentralized clinical trials (DCTs): A few ethical considerations - Frontiers, accessed
February 20, 2025,
https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.1081150/full
20. IRB/EC Considerations for DCT Review – The Multi-Regional Clinical Trials Center of
Brigham and Women's Hospital and Harvard, accessed February 20, 2025,
https://mrctcenter.org/resource/irb-ec-considerations-for-dct-review/
21. Digital endpoints in clinical trials: emerging themes from a multi-stakeholder Knowledge
Exchange event, accessed February 20, 2025,
https://pmc.ncbi.nlm.nih.gov/articles/PMC11297702/
22. How Artificial Intelligence (AI) is Revolutionizing Clinical Trials, accessed February 20, 2025,
https://www.linical.com/articles-research/how-ai-is-revolutionizing-clinical-trials
23. Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs - PMC,
accessed February 20, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC10720846/
24. NIH-developed AI algorithm matches potential volunteers to clinical trials, accessed
February 20, 2025,
https://www.nih.gov/news-events/news-releases/nih-developed-ai-algorithm-matches-potential-v
olunteers-clinical-trials
25. A New Beginning: The Effect of Artificial Intelligence on Clinical Trials, Medicine Creation,
accessed February 20, 2025,
https://www.appliedclinicaltrialsonline.com/view/new-beginning-effect-artificial-intelligence-clinica
l-trials-medicine-creation
26. How AI Can Make Clinical Trials More Efficient, Accessible, and Unbiased - MedStar Health,
accessed February 20, 2025, https://www.medstarhealth.org/blog/weissman-ai-clinical-trials
27. Strategic Partnerships: Collaboration in Clinical Development - TFS HealthScience |
Contract Research Organization | Global Resourcing Provider | CRO, accessed February 20,
2025,
https://tfscro.com/resources/strategic-partnerships-collaborative-cornerstones-in-clinical-develop
ment/